Variant report
Variant | esv12771 |
---|---|
Chromosome Location | chr11:74137378-74140580 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-POLD3-4 | chr11:74139378-74139610 | ENSG00000254631.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000264402 | chromatin interactions |
ENSG00000254631 | chromatin interactions |
ENSG00000165434 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563348161 | chr11:74137439-74137440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs80321348 | chr11:74137459-74137460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549283510 | chr11:74137488-74137489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545239421 | chr11:74137489-74137490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs77922898 | chr11:74137503-74137504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569759653 | chr11:74137528-74137529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189893578 | chr11:74137541-74137542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183704812 | chr11:74137546-74137547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs612040 | chr11:74137551-74137552 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs367836703 | chr11:74137552-74137553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs143810857 | chr11:74137603-74137604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549755491 | chr11:74137630-74137631 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs112060305 | chr11:74137730-74137731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569682707 | chr11:74137743-74137744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146834004 | chr11:74137757-74137758 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370343212 | chr11:74137759-74137760 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs616016 | chr11:74137763-74137764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs144274231 | chr11:74137793-74137794 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534861417 | chr11:74137805-74137806 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557970177 | chr11:74137820-74137821 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs80263265 | chr11:74137834-74137835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs615593 | chr11:74137847-74137848 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs114400394 | chr11:74137852-74137853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs615569 | chr11:74137867-74137868 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551979485 | chr11:74137917-74137918 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs368706168 | chr11:74137927-74137928 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573720642 | chr11:74137929-74137930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs111927345 | chr11:74137939-74137940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs535293752 | chr11:74137945-74137946 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563893822 | chr11:74137963-74137964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs115153902 | chr11:74137981-74137982 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs614757 | chr11:74137998-74137999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565347146 | chr11:74138045-74138046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140932663 | chr11:74138078-74138079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549920880 | chr11:74138088-74138089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201249035 | chr11:74138107-74138108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs182466324 | chr11:74138162-74138163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs528928897 | chr11:74138281-74138282 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187176628 | chr11:74138296-74138297 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
40 | rs566013324 | chr11:74138324-74138325 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs534619765 | chr11:74138325-74138326 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs557896742 | chr11:74138388-74138389 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs571369334 | chr11:74138389-74138390 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs537120554 | chr11:74138456-74138457 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
45 | rs58829591 | chr11:74138493-74138494 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
46 | rs397849737 | chr11:74138494-74138495 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs377125237 | chr11:74138510-74138511 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
48 | rs192422860 | chr11:74138514-74138515 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs150386668 | chr11:74138524-74138525 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
50 | rs542658014 | chr11:74138559-74138560 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chordoma | 21602918 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 21364760 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Leukoplakia | 24403051 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:74129400-74138600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr11:74129400-74141000 | Weak transcription | Rectal Smooth Muscle | rectum |
3 | chr11:74130400-74140200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr11:74137600-74139000 | Enhancers | HUVEC | blood vessel |
5 | chr11:74138200-74138800 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr11:74138600-74138800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr11:74138600-74138800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr11:74138600-74139000 | Enhancers | Osteobl | bone |
9 | chr11:74138800-74161600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr11:74140200-74140400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |